Critical Period for Neonatal Estrogen Exposure in Occurrence of Mammary Gland Abnormalities in Adult Mice

Howard A. Bern, Karen Tanada Mills, Lovell A. Jones

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

There exists a critical period for the development of cervicovaginal lesions in both mice and humans exposed neonatally and antenatally to sex hormones. Mammary glands from year-old female BALB/c mice exposed neonatally to 20 μg estradiol for 5 days commencing at 1 day of age showed the most mammary abnormalities, significantly greater than in controls (P < 0.005). The incidence of abnormalities declined when treatment was begun after Day 1. Treatments begun after Day 3 did not result in this structural pattern. Mice ovariectomized after treatment all had inactive mammary glands with no abnormalities. There is a critical exposure period for the later occurrence of mammary gland abnormalities. However, the aberrant secretory state which accompanies these mammary gland alterations may be a consequence of permanent alteration in ovarian function or its endocrine control.

Original languageEnglish (US)
Pages (from-to)239-242
Number of pages4
JournalProceedings of the Society for Experimental Biology and Medicine
Volume172
Issue number2
DOIs
StatePublished - Feb 1983

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Critical Period for Neonatal Estrogen Exposure in Occurrence of Mammary Gland Abnormalities in Adult Mice'. Together they form a unique fingerprint.

Cite this